ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Minimal By Design: Define MSE Endpoints
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
When to Begin FcRn: Initiation Criteria, Key Evidence
Escalate With Intention: Stepwise, Target-Anchored Moves
The 2-Point Signal: Apply ≥2-Point Rule
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
Clinical Considerations for the Diagnosis of Endometriosis
Linda Bradley, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Lee P. Shulman, MD, FACMG, FACOG
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Pre- and Postoperative Use of GnRH Antagonists
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.